{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:26:24Z","timestamp":1722889584494},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T00:00:00Z","timestamp":1324425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00535-011-0503-x","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T20:45:03Z","timestamp":1324327503000},"page":"377-386","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study"],"prefix":"10.1007","volume":"47","author":[{"name":"FUTURE study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,21]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1440-1746.2006.04446.x","volume":"21","author":"H Miwa","year":"2006","unstructured":"Miwa H, Osada T, Nagahara A, Ohkusa T, Hojo M, Tomita T, et al. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol. 2006;21:1826\u201331.","journal-title":"J Gastroenterol Hepatol"},{"key":"503_CR2","doi-asserted-by":"crossref","unstructured":"Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut. 1999;45(Suppl 2):II37\u201342.","DOI":"10.1136\/gut.45.2008.ii37"},{"key":"503_CR3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack J, Tally NJ, Camilleri M, Holtman G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466\u201379.","journal-title":"Gastroenterology"},{"key":"503_CR4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ajg.2010.66","volume":"105","author":"J Tack","year":"2010","unstructured":"Tack J, Tally NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010;105:757\u201363.","journal-title":"Am J Gastroenterol"},{"key":"503_CR5","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","volume":"100","author":"NJ Tally","year":"2005","unstructured":"Tally NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324\u201337.","journal-title":"Am J Gastroenterol"},{"key":"503_CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2005.02445.x","volume":"21","author":"JM Mason","year":"2005","unstructured":"Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther. 2005;21:1135\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00242.2002","volume":"285","author":"M Simren","year":"2003","unstructured":"Simren M, Vos R, Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2003;285:G309\u201315.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"503_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2007.03367.x","volume":"26","author":"H Miwa","year":"2007","unstructured":"Miwa H, Nakajima K, Yamaguchi K, Fujimoto S, van Zanten SV, Kinoshita Y, et al. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26:257\u201364.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR9","doi-asserted-by":"crossref","first-page":"G278","DOI":"10.1152\/ajpgi.00086.2003","volume":"286","author":"KJ Lee","year":"2004","unstructured":"Lee KJ, Vos R, Janssens J, Tack J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastointest Liver Physiol. 2004;286:G278\u201384.","journal-title":"Am J Physiol Gastointest Liver Physiol."},{"key":"503_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1440-1746.2005.03976.x","volume":"21","author":"KJ Lee","year":"2006","unstructured":"Lee KJ, Kim JH, Cho SA. Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification. J Gastroenterol Heptol. 2006;21:515\u201320.","journal-title":"J Gastroenterol Heptol."},{"issue":"Suppl 2","key":"503_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2005.02472.x","volume":"21","author":"K Kinoshita","year":"2005","unstructured":"Kinoshita K, Hashimoto T, Kawamura A, Yuki M, Amano K, Sato H, et al. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharmacol Ther. 2005;21(Suppl 2):37\u201341.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"503_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2036.2005.02471.x","volume":"21","author":"H Seno","year":"2005","unstructured":"Seno H, Nakase H, Chiba T. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Aliment Pharmacol Ther. 2005;21(Suppl 2):32\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"503_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2036.2005.02470.x","volume":"21","author":"M Kato","year":"2005","unstructured":"Kato M, Watanabe M, Konishi S, Kudo M, Konno J, Meguro T, et al. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia. Aliment Pharmacol Ther. 2005;21(Suppl 2):27\u201331.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjmed.2004.01.008","volume":"116","author":"DA Peura","year":"2004","unstructured":"Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med. 2004;116:740\u20138.","journal-title":"Am J Med"},{"key":"503_CR15","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Shelly S, Deeks JJ, Dalaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;4:CD001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"503_CR16","first-page":"1489","volume":"106","author":"K Furuta","year":"2009","unstructured":"Furuta K, Ishihara S, Sato S, Miyake T, Ishihara N, Koshino K, et al. Development and verification of the Izumo scale, new questionnaire for quality of life assessment of patients with gastrointestinal symptoms. Jpn J Gastroenterol. 2009;106:1489\u201397.","journal-title":"Jpn J Gastroenterol."},{"key":"503_CR17","first-page":"1651","volume":"30","author":"K Furuta","year":"2009","unstructured":"Furuta K, Ishihara S, Sato S, Miyake T, Ishihara N, Koshino K, et al. Investigation of the responsiveness to a change in symptoms in the \u201cIzumo scale\u201d, a questionnaire that assesses QOL in patients with gastrointestinal symptoms. Ther Res. 2009;30:1651\u20137 (in Japanese).","journal-title":"Ther Res"},{"key":"503_CR18","first-page":"192","volume":"59","author":"Y Kinoshita","year":"2010","unstructured":"Kinoshita Y. Investigation of the usefulness of the \u201cIzumo scale\u201d, a QOL questionnaire on gastrointestinal symptoms. J New Remed Clin.2010;59:192\u2013201 (in Japanese).","journal-title":"J New Remed Clin."},{"key":"503_CR19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2169\/internalmedicine.50.5390","volume":"50","author":"E Kakuta","year":"2011","unstructured":"Kakuta E, Yamashita N, Katsube T, Kushiyama Y, Suetsugu H, Furuta K, et al. Abdominal symptom-related QOL in individuals visiting an outpatient clinic and those attending an annual health check. Intern Med. 2011;50:1517\u201322.","journal-title":"Intern Med"},{"key":"503_CR20","unstructured":"Moayyedi P, Soo S, Deeks J, Dalaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2001;1:CD002096."},{"key":"503_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2036.2003.01669.x","volume":"18","author":"T Kamada","year":"2003","unstructured":"Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, et al. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther. 2003;18:245\u201352.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-11-7","volume":"11","author":"CV Nweneka","year":"2011","unstructured":"Nweneka CV, Prentice AM, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels\u2014a systematic review. BMC Gastroenterol. 2011;11:7.","journal-title":"BMC Gastroenterol."},{"key":"503_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","volume":"134","author":"L Laine","year":"2001","unstructured":"Laine L, Schoenfeld P, Fennerty B. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;134:361\u20139.","journal-title":"Ann Intern Med"},{"key":"503_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2036.2000.00706.x","volume":"14","author":"H Miwa","year":"2000","unstructured":"Miwa H, Hirai S, Nagahara A, Murai T, Nishira T, Kikuchi S, et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients\u2014a double-blind placebo controlled study. Aliment Pharmacol Ther. 2000;14:317\u201324.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR25","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1023\/A:1018803129779","volume":"43","author":"AO Quartero","year":"1998","unstructured":"Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJPM, Hoes AX. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci. 1998;43:2028\u201333.","journal-title":"Dig Dis Sci"},{"key":"503_CR26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346\u201352.","journal-title":"Gastroenterology"},{"key":"503_CR27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"98","author":"G Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783\u20138.","journal-title":"Am J Gastroenterol"},{"key":"503_CR28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2982.2009.01449.x","volume":"22","author":"K Matsueda","year":"2010","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia\u2014100\u00a0mg t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010;22:618\u201325.","journal-title":"Neurogastroenterol Motil"},{"key":"503_CR29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2036.2002.01236.x","volume":"16","author":"BI Hallerback","year":"2002","unstructured":"Hallerback BI, Bommelaer G, Bredberg E, Campbell M, Hellblom M, Lauritsen K, et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther. 2002;16:959\u201367.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.2007.132449","volume":"57","author":"NJ Talley","year":"2008","unstructured":"Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008;57:740\u20136.","journal-title":"Gut."},{"key":"503_CR31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"NJ Tally","year":"2000","unstructured":"Tally NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000;14:1653\u201361.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","volume":"5","author":"WH Wang","year":"2007","unstructured":"Wang WH, Huang JQ, Zheng GF, Harry HX, Wong WM, Liu XG, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5:178\u201385.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"503_CR33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Par\u00e9 P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998;12:1055\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1440-1746.2010.06468.x","volume":"26","author":"T Tanimura","year":"2011","unstructured":"Tanimura T, Adachi K, Furuta K, Ohara S, Morita T, Koshino K, et al. Usefulness of catheterless radiotelemetry pH monitoring system to examine the relationship between duodenal acidity and upper gastrointestinal symptoms. J Gastroenterol Hepatol. 2011;26:98\u2013103.","journal-title":"J Gastroenterol Hepatol"},{"key":"503_CR35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e31818e37ab","volume":"43","author":"J Bratten","year":"2009","unstructured":"Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol. 2009;43:527\u201333.","journal-title":"J Clin Gastroenterol"},{"key":"503_CR36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/j.1572-0241.2004.30822.x","volume":"99","author":"KJ Lee","year":"2004","unstructured":"Lee KJ, Demarchi B, Demedts I, Sifrim D, Raeymaekers P, Tack J. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol. 2004;99:1765\u201373.","journal-title":"Am J Gastroenterol"},{"key":"503_CR37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0016-5085(99)70171-X","volume":"116","author":"M Samsom","year":"1999","unstructured":"Samsom M, Verhagen MA, van Berge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999;116:515\u201320.","journal-title":"Gastroenterology"},{"key":"503_CR38","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/j.1572-0241.2001.04103.x","volume":"96","author":"MP Schwartz","year":"2001","unstructured":"Schwartz MP, Samsom M, Smout AJ. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol. 2001;96:2596\u2013602.","journal-title":"Am J Gastroenterol"},{"key":"503_CR39","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1572-0241.2006.00751.x","volume":"101","author":"SV Zanten van","year":"2006","unstructured":"van Zanten SV, Armstrong D, Chiba N, Flook N, White RJ, Chakraborty B, et al. Esomeprazole 40\u00a0mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled \u201cENTER\u201d trial. Am J Gastroenterol. 2006;101:2096\u2013106.","journal-title":"Am J Gastroenterol"},{"key":"503_CR40","doi-asserted-by":"crossref","unstructured":"Kinoshita Y, Chiba T. Characteristics of Japanese patients with chronic gastritis: comparison with functional dyspepsia defined by ROME III criteria\u2014based on large-scale survey: FUTURE study. Intern Med. 2011;50:2269\u20132276","DOI":"10.2169\/internalmedicine.50.5678"},{"key":"503_CR41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.gie.2007.07.007","volume":"66","author":"SO Ikenberry","year":"2007","unstructured":"Ikenberry SO, Harrison ME, Lichtenstein D, Dominita JA, Anderson MA, Jagannath SB, et al. The role of endoscopy in dyspepsia. Gastrointest Endosc. 2007;66:1071\u20135.","journal-title":"Gastrointest Endosc"},{"key":"503_CR42","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1038\/ajg.2009.427","volume":"104","author":"H Miwa","year":"2009","unstructured":"Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009;104:2779\u201387.","journal-title":"Am J Gastroenterol"},{"key":"503_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.2010.04501.x","volume":"33","author":"V Meineche-Schmit","year":"2011","unstructured":"Meineche-Schmit V, Christensen E, Bytzer P. Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care\u2014a randomised, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:41\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"503_CR44","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1572-0241.2005.40280.x","volume":"100","author":"SV Zanten van","year":"2005","unstructured":"van Zanten SV, Chiba N, Armstrong D, Barkun A, Thomason A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol. 2005;100:1477\u201388.","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0503-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0503-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0503-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T23:04:39Z","timestamp":1561071879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0503-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,21]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0503-x","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2011,12,21]]}}}